Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Another Israel ETF Could Be On The Way

Van Eck’s Market Vectors unit, the fifth-largest U.S. ETF issuer by assets under management, has filed plans with the Securities and Exchange Commission to possibly introduce the Market Vectors Israel ETF.

The prospectus filed with the SEC includes ticker and expense ratio information, indicating Market Vectors could be close to bringing the fund to market. The Market Vectors Israel ETF will trade on the New York Stock Exchange under the ticker “ISRA” and have an annual expense ratio of 0.59 percent, according to the filing.

iShares Dow Jones US Home Const. (ETF) (NYSEARCA:ITB)

ISRA will compete directly with the iShares MSCI Israel Capped Inv Mar ETF (NYSEARCA:EIS), which recently turned five years old.

ISRA will track the BlueStar Israel Global Index, which is a a rules based, modified capitalization, free-float adjusted weighted index intended to give investors a means of tracking the overall performance of publicly traded companies that are generally considered to be Israeli companies, according to the filing.

There will be at least one major difference between the new Market Vectors Israel ETF and EIS: Weightings. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) accounts for 22.2 percent of the total weight in EIS, but no stock accounts for more than 12.5 percent of ISRA’s index.

The BlueStar Israel Global Index included 94 securities of companies with a market capitalization range of between approximately $133 million and $35.1 billion and an average market capitalization of $1.9 billion as of March 1, 2013.

EIS has gained 4.6 percent in the past year. Average daily volume in the ETF is almost 18,100 shares.

This article was originally written by The ETF Professor, and posted on Benzinga.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!